Introduction
The mouse Flk1 gene encodes the major signaling receptor, VEGFR2, for the vascular endothelial growth factor, VEGF-A, and is essential for development of the vascular and hematopoietic systems in the early embryo [1] [2] [3] [4] . VEGF signaling through VEGFR2 continues to play key roles in controlling blood vessel development throughout embryogenesis and into the adult 5, 6 . In the early embryo and in differentiating embryonic stem (ES) cells, Flk1 expression seems to mark a common progenitor for both blood and endothelium, the so-called hemangioblast 7, 8 . Recently it has become evident that the expression of Flk1 may mark progenitors with broader potential than just endothelial formation and hematopoiesis. Single
Flk1
+ cells derived from differentiating ES cells can produce cells expressing smooth muscle cell or cardiomyocyte markers in vitro 9, 10 In addition, multipotential cell lines derived from either the embryonic dorsal aorta 11 or from adult bone marrow stroma 12 have been shown to express Flk1.
However, these experiments do not address whether Flk1 expression also marks cells with broad potential in vivo, nor the functional importance of Flk1 for differentiation of lineages other than endothelium and blood lineages.
In situ expression analysis of endogenous Flk1 13 or of a Flk1-lacZ knock-in allele 3 has
shown that Flk1 is expressed in some non-endothelial embryonic cell types, such as the posterior lateral plate mesoderm and the allantois. In addition, sorted Flk1 + cells from E9.5 day embryos have been shown to produce cells expressing smooth muscle cell markers in vitro 14 . Lineage tracing of Flk1-expressing cells using Cre recombinase-mediated cell marking indicated that
Flk1-expressing cells could also contribute progeny to the cardiac and skeletal muscle cell lineages 15 , a finding not predicted by the expression of the endogenous gene. Here we show that the expression of a Flk1-lacZ knock-in allele can also be detected in some cardiomyocytes and in only.
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Examination of lacZ expression in homozygotes for the Flk1lacZ neo-out allele revealed that all Flk1-expressing lineages, other than endothelial and hematopoietic, were still present in the mutants. Thus Flk1 expression marks progenitors with broad mesodermal potential but is not required for the development of all lineages in which it is expressed. 
Materials and Methods

Generation of the Flk1-lacZ neo-out mice
The floxed PGK-neo cassette in our original Flk1 heterozygous mice was removed by crossing with a ubiquitously expressing Cre deleter strain (a gift from A.Nagy). Deletion was verified by Southern analysis.
Generation of the Flk1-GFP neo-out mice EGFP cDNA (Clontech) was introduced into the first exon of the Flk1 gene as before 3 and the targeting vector was electroporated into R1 ES cells 17 . Correctly targeted events were identified by Southern blot analysis (data not shown). After successful germ line transmission of the targeted allele, the floxed PGK-neo cassette was removed by crossing with a Cre deleter strain and verified by Southern analysis.
Construction of the Flk1-lacZ knock-in vector lacking first intronic enhancer and establishment of targeted ES cell lines
The Flk1-lacZ knock-in vector lacking the first intronic enhancer was constructed as 
Generation of mice from the ES cell lines
Chimeric mice were generated by diploid aggregation with ICR outbred embryos as described previously 17 .
X -gal staining
The dissected embryos were stained with X-gal as described previously 3 and were staged according to Downs and Davies 18 . The embryos were post-fixed with 4% PFA, sectioned and counterstained with FastRed.
Immunohistochemistry
The 8.5 dpc embryos were dissected and fixed with 4% PFA overnight. After washing with PBS, the embryos were soaked in 30% sucrose, mounted in OCT compound and 4µm cryosections were prepared. After blocking reaction in PBSMT (PBS+2% skim milk + 0.1% Tween20) for 1 h, the sections were incubated with rat anti-Flk1 antibody (clone AVAS12, BD 3 . However, lacZ expression in minor blood vessels of the yolk sac at 13.5 dpc is weak compared with Flk1 antibody staining ( Fig.2A,D) , as previously reported by Kappel et al 16 . They proposed that a cis-element(s) in the small region of the 5' UTR that was removed in our lacZ knock-in mice might be critical for full recapitulation of Flk1 expression 16 . However, it is also possible that the PGK-neo cassette in the targeted Flk1 allele interferes with lacZ transcription from the Flk1 promoter, since transcriptional interference between two genes transcribed in parallel can occur very effectively 19 .
We removed the PGK-neo cassette of Flk1+/lacZ neo-in mice by crossing with a Credeleter strain to establish Flk1 +/lacZ neo-out mice. The yolk sac of Flk1 +/lacZ neo-out embryos at 13.5 dpc showed much stronger β−galactosidase activity than Flk1 +/lacZ neo-in embryos ( Fig.2B ) with β-galactosidase signal apparent in most, if not all, blood vessels. We also performed a time course experiment by staining embryos for 1, 4 and 24 hrs in X-gal and estimated that the blood vessels in both embryonic and extra-embryonic regions were stained 4-10 fold more intensively in Flk1 +/lacZ neo-out embryos than in Flk1 +/lacZ neo-in embryos (Fig.3 ). The removal of the PGK-neo cassette also resulted in the up-regulation of lacZ expression in endothelial cells in the adult (Fig.3) . We thus conclude that there is no evidence for any important regulatory element in the region of the 5'UTR deleted in the Flk1-lacZ neo-out allele, but rather that the inclusion of the neo cassette in the knock-in allele interferes with full expression from the Flk1 locus.
only.
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The earliest stage at which we could detect the lacZ signal was the mid-streak stage of gastrulation (Fig.4A) . LacZ was expressed in all mesoderm cells exiting from the primitive streak in the proximal-posterior region but not in cells arising from the distal-anterior region of the streak that will give rise to node and axial mesoderm ( Fig.4D-H ). The cells of the streak itself were negative for Flk1-lacZ expression but lacZ turned on as cells exited the streak ( Moderate Flk1 protein expression was confirmed in myocardial cells co-expressing MHC and GATA4, as well as the endocardial cells of the heart. Moderate Flk1 protein expression was also seen in dorsolateral part of the somite co-localized with Pax3 ( Fig. 5 ) and cells migrating out of the somite (Fig. 5) . Flk1-Pax3 double positive cells were observed inside the somite and migrating out of the somite along the whole body axis (data not shown).
Effect of deletion of 1st intronic enhancer on Flk1 gene expression
Kappel and coworkers identified an enhancer within the first intron as sufficient for Flk1 expression in angioblasts and endothelial cells in transgenic animals 16 . They also showed that Tal1, GATA2 and Ets factors act cooperatively on the enhancer to direct endothelial expression 21 .
To determine whether this enhancer sequence is also required for Flk1 expression in other mesodermal lineages, we constructed a lacZ knock-in vector for the Flk1 locus that lacks the enhancer sequence from the SwaI to the BamHI site (Fig.1) . The targeting vector was introduced into ES cells and targeting events were confirmed by Southern analysis (data not shown). The deletion of the enhancer sequence was confirmed by PCR analysis using the primers flanking the enhancer (Fig.1B) . After germ-line transmission of the targeted allele, the PGK-neo cassette was removed by Cre excision as before. Removal of the neo cassette increased lacZ activity as observed in Flk1 +/lacZ neo-in/out mice (data not shown). Comparison of the levels and location of X-gal staining between the Flk1 +/lacZ del Sw/B neo-out and the Flk +/lacZ neo-out embryos revealed no significant differences in lacZ activity (Fig.3) . LacZ signal was seen in most of the only.
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Thus deletion of the 1st intronic enhancer sequence did not change pattern or level of the lacZ expression significantly, indicating that, while this enhancer may be sufficient for endothelial expression, it is not necessary for induction or maintenance of Flk1 expression in any of its wellcharacterized domains of expression.
Generation of Flk1-GFP mice
Given the evidence that the knockin allele of Flk1 can replicate the full endogenous expression of Flk1 once the selection cassette used for targeted clone selection was removed, we made another targeting construct replacing lacZ with the EGFP reporter. After germline transmission, without neo excision it was difficult to observe GFP expression (Fig.6B) . However, after neo excision, the GFP knockin allele produced clear fluorescence in all domains of Flk1 expression even from the primitive streak stage (Fig.6C-F) . This allele should therefore prove very useful for separating and analyzing Flk1 + progenitors at different stages of development.
Contribution of Flk1-null cells to cardiac and skeletal muscle cells
Flk1 is necessary for the development of hematopoietic and endothelial cells in the embryo 3, 4 . Since Flk1 appears to be expressed in a broader spectrum of mesodermal lineages, we asked whether or not Flk1 is also required for the development of these cells by investigating the contribution of Flk1-null cells (LacZ+ cells) to these lineages. At 8.0 dpc, strong or moderate only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From lacZ expression was seen in heart crescent, amniotic, allantoic and chorionic mesoderm and mesothelium of homozygous Flk1lacZ neo-out embryos after 8 hrs X-gal staining, while blood island cells and angioblasts were absent (Fig.7A, B) . At 8.5 dpc, lacZ signals persisted in splanchnic mesoderm, myocardium, and the dorsolateral part of the somites, although all blood vessels were absent (Fig.7C, D) . No obvious morphological abnormalities were seen in the nonendothelial Flk1-lacZ-expressing cell lineages in the null mutants. Thus, Flk1 seems to be indispensable for hematopoietic and endothelial development, but not for other mesodermal lineages expressing the marker.
Discussion
By deleting the neomycin resistance cassette in the previously described Flk1-lacZ knock-in allele, we have found that Flk1 expression marks a broad spectrum of mesodermal progenitors including cardiac and skeletal muscle precursors in the early mouse embryo. Our findings are consistent with the recent cell fate tracing experiment by Motoike and coworkers, using Cre mice under the control of Flk1 promoter, crossed with lacZ Cre-reporter mice 15 . Thus further investigation of the identity of the Flk1 positive precursors in the somites is needed.
We also observed widespread expression of Flk1-lacZ in all the mesoderm lineages derived from the posterior of the primitive streak, namely all extraembryonic mesoderm cells as well as embryonic splanchnic mesoderm. We previously reported that, in Flk1 null mutants,
Flk1
-lacZ expressing cells were observed in the amniotic mesoderm and splanchnic mesoderm in apparently increased numbers over Flk1-lacZ heterozygotes 3 . We suggested that, in the absence of active Flk1 signaling, Flk1-expressing progenitors that would normally make endothelium and blood islands were redirected into these other lineages. However, it now seems likely that this apparent redirection simply reflects the increased level of lacZ expression in the homozygous embryos, allowing detection of expression in these cells. In this current study, extensive Flk1-lacZ expression was observed in amniotic mesoderm, yolk sac mesothelium and splanchnic mesoderm in heterozygous as well as homozygous mice. No obvious difference in patterns of expression was observed in these lineages between the two genotypes. Thus it seems that Flk1 expression marks a broad range of mesoderm cells at gastrulation, but is only required functionally in endothelium and hematopoietic cells.
Expression of Flk1, as revealed by the lacZ and GFP alleles generated here, seems to mark mesodermal progenitors arising from a specific region of the primitive streak, as well as can be isolated directly from the primitive streak of 7.5 day mouse embryos 8 .
Accumulating evidence indicates that Flk1 may mark other types of multipotent stem cell populations in the adult and during embryogenesis. Multipotential mesenchymal stem cells isolated from adult bone marrow express Flk1 protein, although the expression level is moderate 12 . Flk1 is also a marker of hematopoietic stem cells in adult bone marrow 28 .
Multipotent mesodermal (mesoangioblast) cells derived from developing dorsal aorta express
Flk1 and have the potential to differentiate into many types of mesodermal cells 11 . Yamashita and coworkers claimed that there is a common Flk1+progenitor that give rise to both smooth muscle and endothelial cells in the embryo 9 . We have proposed that the Flk1+ population represents a pool of progenitors that can make multiple mesodermal cell types, dependent on the co-expression of different transcription factors 29 and showed that levels of one such transcription factor, Scl/Tal1, could alter the fate of the Flk1 progenitor 14 . Gering and coworkers showed that over-expression of lmo2 and SCL, downstream genes from Flk1, in zebrafish causes cell fate skewing from mesodermal cells towards endothelial cells in head, pronephros and cardiac mesoderm in the absence of GATA-1 30 .
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